Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroma × Ralfinamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neuroma 1

Interventions

Bupivacaine 2 Ultrasonography 1 Therapeutics 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Ralfinamide 1 Radiofrequency Ablation 1 Nerve Conduction Studies 1 Musculoskeletal Manipulations 1 Methylprednisolone 1 Lidoderm 1 Lidocaine 1 Indocyanine Green 1 Dry Needling 1 Decompression 1 Cryosurgery 1 Cholecalciferol 1 Bevacizumab 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01019824 2017-09-15

Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain

Newron Pharmaceuticals SPA

Phase 3 Completed

Neuroma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡